Liminatus Pharma Inc Cl A (LIMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,124 | -10,207 | -2,038 | -214 | -328 |
| Depreciation Amortization | 1 | 2 | 1 | 1 | N/A |
| Other Working Capital | -881 | -3,495 | -3,853 | -2,182 | 186 |
| Other Operating Activity | -11 | 3,736 | -3,687 | -6,580 | -18 |
| Operating Cash Flow | $-2,015 | $-9,963 | $-9,577 | $-8,976 | $-159 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -13 | -13 | N/A | N/A |
| Net Acquisitions | N/A | -775 | -775 | -775 | -575 |
| Investing Cash Flow | $N/A | $-788 | $-788 | $-775 | $-575 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 4,340 | 4,340 | 4,340 | 713 |
| Common Stock Issued | 3,585 | 10,557 | 10,557 | 10,557 | N/A |
| Other Financing Activity | 0 | -3,864 | -3,864 | -3,864 | 0 |
| Financing Cash Flow | $3,585 | $11,033 | $11,033 | $11,033 | $713 |
| Beginning Cash Position | 338 | 56 | 56 | 56 | 56 |
| End Cash Position | 1,908 | 338 | 725 | 1,338 | 35 |
| Net Cash Flow | $1,570 | $281 | $668 | $1,282 | $-21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,015 | -9,963 | -9,577 | -8,976 | -159 |
| Capital Expenditure | N/A | -13 | -13 | N/A | N/A |
| Free Cash Flow | -2,015 | -9,976 | -9,590 | -8,976 | -159 |